Aesthetic injectables, often known as dermal fillers, are medications that help with bioengineering or face rejuvenation. As people become older, their facial skin loses subcutaneous fat & draws closer to their facial muscles, causing more visible smile lines and wrinkles. As a result of this, the facial skin stretches, resulting to volume loss. These concerns can be addressed with aesthetic injectables or dermal fillers, which aid in the treatment of early signs of ageing or add benefit to a facial rejuvenation process.
The global market for Aesthetics Injectable was estimated to be worth US$ 8230 million in 2023 and is forecast to a readjusted size of US$ 14030 million by 2030 with a CAGR of 7.9% during the forecast period 2024-2030
The global aesthetics injectable market refers to the market for injectable cosmetic treatments and procedures that are used to enhance the appearance of individuals. These injectables are typically administered by healthcare professionals and include products such as dermal fillers and botulinum toxin.
Here are the key factors influencing the growth of the global aesthetics injectable market:
Increasing demand for minimally invasive procedures: There is a growing preference among individuals for non-surgical and minimally invasive options to enhance their appearance. Aesthetics injectables provide a less invasive alternative to surgical procedures, allowing for facial rejuvenation, wrinkle reduction, and facial contouring without the need for extensive downtime or surgery. This increasing demand for less invasive treatments is driving the growth of the aesthetics injectable market.
Growing emphasis on youthful appearance: The desire to maintain a youthful and aesthetically pleasing appearance is driving the demand for aesthetics injectables. Factors such as increasing exposure to social media, the influence of celebrities, and cultural norms regarding beauty and youthfulness contribute to the growing demand for injectables to address concerns such as wrinkles, fine lines, volume loss, and sagging skin.
Advancements in product formulations and technology: The aesthetics injectable market has witnessed significant advancements in product formulations and delivery techniques. Manufacturers are continuously developing new injectables with improved properties, longer-lasting effects, and enhanced safety profiles. Additionally, technological advancements, such as the use of microcannulas and advanced injection techniques, have contributed to improved patient outcomes and increased acceptance of injectable procedures.
Expanding target demographic: The market for aesthetics injectables was initially driven by the demand from middle-aged and older individuals. However, there is now a growing trend of younger individuals seeking preventative and enhancement treatments at an earlier age. This expanding target demographic, including millennials and Generation Z, is contributing to the overall growth of the aesthetics injectable market.
Increasing awareness and acceptance: Greater awareness about available aesthetic options, along with the dissemination of information through social media, online platforms, and clinics, has led to increased acceptance of aesthetics injectables. As the stigma around cosmetic procedures diminishes and more people become aware of the benefits and safety of injectables, the market continues to grow.
Rising disposable incomes and affordability: Aesthetics injectables were traditionally considered a luxury accessible only to a limited segment of the population. However, rising disposable incomes in many regions, along with increased affordability and accessibility of treatments, have expanded the customer base. This has led to a wider adoption of aesthetics injectables and driven market growth.
In summary, the global aesthetics injectable market is driven by factors such as the increasing demand for minimally invasive procedures, the growing emphasis on a youthful appearance, advancements in product formulations and technology, expanding target demographics, increasing awareness and acceptance, and rising disposable incomes. As more individuals seek aesthetic treatments and manufacturers continue to innovate and improve their product offerings, the global aesthetics injectable market is projected to experience significant growth in the foreseeable future.The global aesthetics injectable market refers to the market for injectable cosmetic treatments and procedures that are used to enhance the appearance of individuals. These injectables are typically administered by healthcare professionals and include products such as dermal fillers and botulinum toxin.
Here are the key factors influencing the growth of the global aesthetics injectable market:
Increasing demand for minimally invasive procedures: There is a growing preference among individuals for non-surgical and minimally invasive options to enhance their appearance. Aesthetics injectables provide a less invasive alternative to surgical procedures, allowing for facial rejuvenation, wrinkle reduction, and facial contouring without the need for extensive downtime or surgery. This increasing demand for less invasive treatments is driving the growth of the aesthetics injectable market.
Growing emphasis on youthful appearance: The desire to maintain a youthful and aesthetically pleasing appearance is driving the demand for aesthetics injectables. Factors such as increasing exposure to social media, the influence of celebrities, and cultural norms regarding beauty and youthfulness contribute to the growing demand for injectables to address concerns such as wrinkles, fine lines, volume loss, and sagging skin.
Advancements in product formulations and technology: The aesthetics injectable market has witnessed significant advancements in product formulations and delivery techniques. Manufacturers are continuously developing new injectables with improved properties, longer-lasting effects, and enhanced safety profiles. Additionally, technological advancements, such as the use of microcannulas and advanced injection techniques, have contributed to improved patient outcomes and increased acceptance of injectable procedures.
Expanding target demographic: The market for aesthetics injectables was initially driven by the demand from middle-aged and older individuals. However, there is now a growing trend of younger individuals seeking preventative and enhancement treatments at an earlier age. This expanding target demographic, including millennials and Generation Z, is contributing to the overall growth of the aesthetics injectable market.
Increasing awareness and acceptance: Greater awareness about available aesthetic options, along with the dissemination of information through social media, online platforms, and clinics, has led to increased acceptance of aesthetics injectables. As the stigma around cosmetic procedures diminishes and more people become aware of the benefits and safety of injectables, the market continues to grow.
Rising disposable incomes and affordability: Aesthetics injectables were traditionally considered a luxury accessible only to a limited segment of the population. However, rising disposable incomes in many regions, along with increased affordability and accessibility of treatments, have expanded the customer base. This has led to a wider adoption of aesthetics injectables and driven market growth.
In summary, the global aesthetics injectable market is driven by factors such as the increasing demand for minimally invasive procedures, the growing emphasis on a youthful appearance, advancements in product formulations and technology, expanding target demographics, increasing awareness and acceptance, and rising disposable incomes. As more individuals seek aesthetic treatments and manufacturers continue to innovate and improve their product offerings, the global aesthetics injectable market is projected to experience significant growth in the foreseeable future.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Aesthetics Injectable, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Aesthetics Injectable by region & country, by Type, and by Application.
The Aesthetics Injectable market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aesthetics Injectable.
麻豆原创 Segmentation
By Company
Luminera
ALLERGAN
Anika Therapeutics, Inc.,
Medytox
Merz Pharma
Nestl茅 Skin Health
Galderma Laboratories, L.P
Sinclair Pharma
Suneva Medical
Teoxane
Advanced Dermatology and Cosmetic Surgery
Bausch Health
Sanofi
Ipsen Pharma
Integra LifeSciences Corporation
FibroGen, Inc.
Medical Devices Business Services, Inc.,
DR. Korman
Shanghai Fosun Pharmaceutical锛圙roup锛塁o., Ltd.
Cynosure LLC
Segment by Type:
Wrinkle Relaxers
Dermal Fillers
Segment by Application
Facial Line Correction
Lip Augmentation
Face Lift
Acne Scar Treatment
Lipoatrophy Treatment
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Aesthetics Injectable manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Aesthetics Injectable in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Aesthetics Injectable in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Aesthetics Injectable Product Introduction
1.2 Global Aesthetics Injectable 麻豆原创 Size Forecast
1.2.1 Global Aesthetics Injectable Sales Value (2019-2030)
1.2.2 Global Aesthetics Injectable Sales Volume (2019-2030)
1.2.3 Global Aesthetics Injectable Sales Price (2019-2030)
1.3 Aesthetics Injectable 麻豆原创 Trends & Drivers
1.3.1 Aesthetics Injectable Industry Trends
1.3.2 Aesthetics Injectable 麻豆原创 Drivers & Opportunity
1.3.3 Aesthetics Injectable 麻豆原创 Challenges
1.3.4 Aesthetics Injectable 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Aesthetics Injectable Players Revenue Ranking (2023)
2.2 Global Aesthetics Injectable Revenue by Company (2019-2024)
2.3 Global Aesthetics Injectable Players Sales Volume Ranking (2023)
2.4 Global Aesthetics Injectable Sales Volume by Company Players (2019-2024)
2.5 Global Aesthetics Injectable Average Price by Company (2019-2024)
2.6 Key Manufacturers Aesthetics Injectable Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Aesthetics Injectable Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Aesthetics Injectable
2.9 Aesthetics Injectable 麻豆原创 Competitive Analysis
2.9.1 Aesthetics Injectable 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Aesthetics Injectable Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aesthetics Injectable as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Wrinkle Relaxers
3.1.2 Dermal Fillers
3.2 Global Aesthetics Injectable Sales Value by Type
3.2.1 Global Aesthetics Injectable Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Aesthetics Injectable Sales Value, by Type (2019-2030)
3.2.3 Global Aesthetics Injectable Sales Value, by Type (%) (2019-2030)
3.3 Global Aesthetics Injectable Sales Volume by Type
3.3.1 Global Aesthetics Injectable Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Aesthetics Injectable Sales Volume, by Type (2019-2030)
3.3.3 Global Aesthetics Injectable Sales Volume, by Type (%) (2019-2030)
3.4 Global Aesthetics Injectable Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Facial Line Correction
4.1.2 Lip Augmentation
4.1.3 Face Lift
4.1.4 Acne Scar Treatment
4.1.5 Lipoatrophy Treatment
4.1.6 Other
4.2 Global Aesthetics Injectable Sales Value by Application
4.2.1 Global Aesthetics Injectable Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Aesthetics Injectable Sales Value, by Application (2019-2030)
4.2.3 Global Aesthetics Injectable Sales Value, by Application (%) (2019-2030)
4.3 Global Aesthetics Injectable Sales Volume by Application
4.3.1 Global Aesthetics Injectable Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Aesthetics Injectable Sales Volume, by Application (2019-2030)
4.3.3 Global Aesthetics Injectable Sales Volume, by Application (%) (2019-2030)
4.4 Global Aesthetics Injectable Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Aesthetics Injectable Sales Value by Region
5.1.1 Global Aesthetics Injectable Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Aesthetics Injectable Sales Value by Region (2019-2024)
5.1.3 Global Aesthetics Injectable Sales Value by Region (2025-2030)
5.1.4 Global Aesthetics Injectable Sales Value by Region (%), (2019-2030)
5.2 Global Aesthetics Injectable Sales Volume by Region
5.2.1 Global Aesthetics Injectable Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Aesthetics Injectable Sales Volume by Region (2019-2024)
5.2.3 Global Aesthetics Injectable Sales Volume by Region (2025-2030)
5.2.4 Global Aesthetics Injectable Sales Volume by Region (%), (2019-2030)
5.3 Global Aesthetics Injectable Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Aesthetics Injectable Sales Value, 2019-2030
5.4.2 North America Aesthetics Injectable Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Aesthetics Injectable Sales Value, 2019-2030
5.5.2 Europe Aesthetics Injectable Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Aesthetics Injectable Sales Value, 2019-2030
5.6.2 Asia Pacific Aesthetics Injectable Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Aesthetics Injectable Sales Value, 2019-2030
5.7.2 South America Aesthetics Injectable Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Aesthetics Injectable Sales Value, 2019-2030
5.8.2 Middle East & Africa Aesthetics Injectable Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Aesthetics Injectable Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Aesthetics Injectable Sales Value
6.2.1 Key Countries/Regions Aesthetics Injectable Sales Value, 2019-2030
6.2.2 Key Countries/Regions Aesthetics Injectable Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Aesthetics Injectable Sales Value, 2019-2030
6.3.2 United States Aesthetics Injectable Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Aesthetics Injectable Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Aesthetics Injectable Sales Value, 2019-2030
6.4.2 Europe Aesthetics Injectable Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Aesthetics Injectable Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Aesthetics Injectable Sales Value, 2019-2030
6.5.2 China Aesthetics Injectable Sales Value by Type (%), 2023 VS 2030
6.5.3 China Aesthetics Injectable Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Aesthetics Injectable Sales Value, 2019-2030
6.6.2 Japan Aesthetics Injectable Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Aesthetics Injectable Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Aesthetics Injectable Sales Value, 2019-2030
6.7.2 South Korea Aesthetics Injectable Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Aesthetics Injectable Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Aesthetics Injectable Sales Value, 2019-2030
6.8.2 Southeast Asia Aesthetics Injectable Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Aesthetics Injectable Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Aesthetics Injectable Sales Value, 2019-2030
6.9.2 India Aesthetics Injectable Sales Value by Type (%), 2023 VS 2030
6.9.3 India Aesthetics Injectable Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Luminera
7.1.1 Luminera Company Information
7.1.2 Luminera Introduction and Business Overview
7.1.3 Luminera Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Luminera Aesthetics Injectable Product Offerings
7.1.5 Luminera Recent Development
7.2 ALLERGAN
7.2.1 ALLERGAN Company Information
7.2.2 ALLERGAN Introduction and Business Overview
7.2.3 ALLERGAN Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.2.4 ALLERGAN Aesthetics Injectable Product Offerings
7.2.5 ALLERGAN Recent Development
7.3 Anika Therapeutics, Inc.,
7.3.1 Anika Therapeutics, Inc., Company Information
7.3.2 Anika Therapeutics, Inc., Introduction and Business Overview
7.3.3 Anika Therapeutics, Inc., Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Anika Therapeutics, Inc., Aesthetics Injectable Product Offerings
7.3.5 Anika Therapeutics, Inc., Recent Development
7.4 Medytox
7.4.1 Medytox Company Information
7.4.2 Medytox Introduction and Business Overview
7.4.3 Medytox Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Medytox Aesthetics Injectable Product Offerings
7.4.5 Medytox Recent Development
7.5 Merz Pharma
7.5.1 Merz Pharma Company Information
7.5.2 Merz Pharma Introduction and Business Overview
7.5.3 Merz Pharma Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Merz Pharma Aesthetics Injectable Product Offerings
7.5.5 Merz Pharma Recent Development
7.6 Nestl茅 Skin Health
7.6.1 Nestl茅 Skin Health Company Information
7.6.2 Nestl茅 Skin Health Introduction and Business Overview
7.6.3 Nestl茅 Skin Health Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Nestl茅 Skin Health Aesthetics Injectable Product Offerings
7.6.5 Nestl茅 Skin Health Recent Development
7.7 Galderma Laboratories, L.P
7.7.1 Galderma Laboratories, L.P Company Information
7.7.2 Galderma Laboratories, L.P Introduction and Business Overview
7.7.3 Galderma Laboratories, L.P Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Galderma Laboratories, L.P Aesthetics Injectable Product Offerings
7.7.5 Galderma Laboratories, L.P Recent Development
7.8 Sinclair Pharma
7.8.1 Sinclair Pharma Company Information
7.8.2 Sinclair Pharma Introduction and Business Overview
7.8.3 Sinclair Pharma Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Sinclair Pharma Aesthetics Injectable Product Offerings
7.8.5 Sinclair Pharma Recent Development
7.9 Suneva Medical
7.9.1 Suneva Medical Company Information
7.9.2 Suneva Medical Introduction and Business Overview
7.9.3 Suneva Medical Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Suneva Medical Aesthetics Injectable Product Offerings
7.9.5 Suneva Medical Recent Development
7.10 Teoxane
7.10.1 Teoxane Company Information
7.10.2 Teoxane Introduction and Business Overview
7.10.3 Teoxane Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Teoxane Aesthetics Injectable Product Offerings
7.10.5 Teoxane Recent Development
7.11 Advanced Dermatology and Cosmetic Surgery
7.11.1 Advanced Dermatology and Cosmetic Surgery Company Information
7.11.2 Advanced Dermatology and Cosmetic Surgery Introduction and Business Overview
7.11.3 Advanced Dermatology and Cosmetic Surgery Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Advanced Dermatology and Cosmetic Surgery Aesthetics Injectable Product Offerings
7.11.5 Advanced Dermatology and Cosmetic Surgery Recent Development
7.12 Bausch Health
7.12.1 Bausch Health Company Information
7.12.2 Bausch Health Introduction and Business Overview
7.12.3 Bausch Health Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Bausch Health Aesthetics Injectable Product Offerings
7.12.5 Bausch Health Recent Development
7.13 Sanofi
7.13.1 Sanofi Company Information
7.13.2 Sanofi Introduction and Business Overview
7.13.3 Sanofi Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Sanofi Aesthetics Injectable Product Offerings
7.13.5 Sanofi Recent Development
7.14 Ipsen Pharma
7.14.1 Ipsen Pharma Company Information
7.14.2 Ipsen Pharma Introduction and Business Overview
7.14.3 Ipsen Pharma Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Ipsen Pharma Aesthetics Injectable Product Offerings
7.14.5 Ipsen Pharma Recent Development
7.15 Integra LifeSciences Corporation
7.15.1 Integra LifeSciences Corporation Company Information
7.15.2 Integra LifeSciences Corporation Introduction and Business Overview
7.15.3 Integra LifeSciences Corporation Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Integra LifeSciences Corporation Aesthetics Injectable Product Offerings
7.15.5 Integra LifeSciences Corporation Recent Development
7.16 FibroGen, Inc.
7.16.1 FibroGen, Inc. Company Information
7.16.2 FibroGen, Inc. Introduction and Business Overview
7.16.3 FibroGen, Inc. Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.16.4 FibroGen, Inc. Aesthetics Injectable Product Offerings
7.16.5 FibroGen, Inc. Recent Development
7.17 Medical Devices Business Services, Inc.,
7.17.1 Medical Devices Business Services, Inc., Company Information
7.17.2 Medical Devices Business Services, Inc., Introduction and Business Overview
7.17.3 Medical Devices Business Services, Inc., Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Medical Devices Business Services, Inc., Aesthetics Injectable Product Offerings
7.17.5 Medical Devices Business Services, Inc., Recent Development
7.18 DR. Korman
7.18.1 DR. Korman Company Information
7.18.2 DR. Korman Introduction and Business Overview
7.18.3 DR. Korman Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.18.4 DR. Korman Aesthetics Injectable Product Offerings
7.18.5 DR. Korman Recent Development
7.19 Shanghai Fosun Pharmaceutical锛圙roup锛塁o., Ltd.
7.19.1 Shanghai Fosun Pharmaceutical锛圙roup锛塁o., Ltd. Company Information
7.19.2 Shanghai Fosun Pharmaceutical锛圙roup锛塁o., Ltd. Introduction and Business Overview
7.19.3 Shanghai Fosun Pharmaceutical锛圙roup锛塁o., Ltd. Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Shanghai Fosun Pharmaceutical锛圙roup锛塁o., Ltd. Aesthetics Injectable Product Offerings
7.19.5 Shanghai Fosun Pharmaceutical锛圙roup锛塁o., Ltd. Recent Development
7.20 Cynosure LLC
7.20.1 Cynosure LLC Company Information
7.20.2 Cynosure LLC Introduction and Business Overview
7.20.3 Cynosure LLC Aesthetics Injectable Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Cynosure LLC Aesthetics Injectable Product Offerings
7.20.5 Cynosure LLC Recent Development
8 Industry Chain Analysis
8.1 Aesthetics Injectable Industrial Chain
8.2 Aesthetics Injectable Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Aesthetics Injectable Sales Model
8.5.2 Sales Channel
8.5.3 Aesthetics Injectable Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Luminera
ALLERGAN
Anika Therapeutics, Inc.,
Medytox
Merz Pharma
Nestl茅 Skin Health
Galderma Laboratories, L.P
Sinclair Pharma
Suneva Medical
Teoxane
Advanced Dermatology and Cosmetic Surgery
Bausch Health
Sanofi
Ipsen Pharma
Integra LifeSciences Corporation
FibroGen, Inc.
Medical Devices Business Services, Inc.,
DR. Korman
Shanghai Fosun Pharmaceutical锛圙roup锛塁o., Ltd.
Cynosure LLC
听
听
*If Applicable.
